Synthetic Mid-urethral Sling for the Treatment of Urinary Incontinence in Women With Neurogenic Lower Urinary Tract Dysfunction: A Multicentric Retrospective Study.


Journal

The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374

Informations de publication

Date de publication:
06 2023
Historique:
medline: 10 5 2023
pubmed: 23 2 2023
entrez: 22 2 2023
Statut: ppublish

Résumé

We assess the efficacy, safety, and predictive factors for failure of synthetic mid-urethral slings for the treatment of urinary incontinence in a large cohort of women with neurogenic lower urinary tract dysfunction. Women aged 18 years or older who received a synthetic mid-urethral sling for stress urinary incontinence or mixed urinary incontinence in 3 centers between 2004 and 2019 and who had a neurological disorder were included. Exclusion criteria were less than 1 year of follow-up, concomitant pelvic organ prolapse repair, previous synthetic sling implantation, and no baseline urodynamics. The primary outcome was surgical failure, defined as recurrence of stress urinary incontinence during follow-up. Kaplan-Meier analysis was used to estimate the 5-year failure rate. Adjusted Cox proportional hazard model was used to identify factors associated with surgical failure. Complications and reoperations during the follow-up have also been reported. A total of 115 women with a median age of 53 years were included Synthetic mid-urethral slings may be an acceptable alternative to autologous slings or artificial urinary sphincters for the treatment of stress urinary incontinence in a selected group of patients with neurogenic lower urinary tract dysfunction.

Identifiants

pubmed: 36812396
doi: 10.1097/JU.0000000000003388
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1176-1183

Commentaires et corrections

Type : CommentIn

Auteurs

Clement Sarrazin (C)

Univ. Grenoble Alpes, Chirurgie urologique et de la transplantation rénale, CHU Grenoble Alpes, 38000 Grenoble, France.

Olivier Laurent Windisch (OL)

Division of Urologic Surgery, Geneva University Hospital, Genève, Switzerland.

Maximilien Baron (M)

Department of Urology, Nantes University Hospital, Nantes, France.

Bernard Boillot (B)

Univ. Grenoble Alpes, Chirurgie urologique et de la transplantation rénale, CHU Grenoble Alpes, 38000 Grenoble, France.

Caroline Thuillier (C)

Univ. Grenoble Alpes, Chirurgie urologique et de la transplantation rénale, CHU Grenoble Alpes, 38000 Grenoble, France.

Chloé Lefevre (C)

Department of Physical Medicine and Rehabilitation, Nantes University Hospital, Nantes, France.

Brigitte Perrouin-Verbe (B)

Department of Physical Medicine and Rehabilitation, Nantes University Hospital, Nantes, France.

Alain Ruffion (A)

Department of Urology, Lyon Sud Hospital-Pierre-Bénite, University of Lyon, Lyon, France.

Marie-Aimee Perrouin-Verbe (MA)

Department of Urology, Nantes University Hospital, Nantes, France.
University of Nantes, U 1235 TENS, Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH